Interestingly, in the off treatment group, we identified significant changes in the tumor microenvironment, with a decrease in tumor macrophages, reduction in inflammatory dendritic cells, and a significant decrease in CD8 T-effector cells treated with single-agent C5AR inhibition. This evidence concerns the gene CD8A and neoplasm.